Cost-effectiveness of Ivabradine as a Treatment for Systolic Chronic Heart Failure in the United States

被引：0
|
作者：
Kansal, Anuraag R.
Cowie, Martin
Kielhorn, Adrian
Krotneva, Stanimira
Taffazzoli, Ali
Zheng, Ying
Yurgin, Nicole
机构：
来源：
CIRCULATION | 2015年 / 132卷
关键词：
cost effectiveness; systolic chronic heart failure; ivabradine; quality-adjusted life years; hospitalization;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17655
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [41] The Cost-effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United States
    Tremblay, Gabriel
    Dolph, Mike
    Roy, Anuja Nidumolu
    Said, Qayyim
    Forsythe, Anna
    CLINICAL THERAPEUTICS, 2020, 42 (05) : 860 - +
  • [42] Ivabradine as adjuvant treatment for chronic heart failure
    Benstoem, Carina
    Kalvelage, Christina
    Breuer, Thomas
    Heussen, Nicole
    Marx, Gernot
    Stoppe, Christian
    Brandenburg, Vincent
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (11):
  • [43] Cost-Effectiveness of Dapagliflozin vs Empagliflozin for Treating Heart Failure With Reduced Ejection Fraction in the United States
    Nechi, Regina Nwamaka
    Rane, Amey
    Karaye, Rukayyah M.
    Ndikumukiza, Cyrille
    Alsahali, Saud
    Jatau, Abubakar I.
    Zoni, Cesar Rodrigo
    Alanzi, Abdullah
    Karaye, Ibraheem M.
    Yunusa, Ismaeel
    CLINICAL THERAPEUTICS, 2023, 45 (07) : 627 - 632
  • [44] SYSTEMATIC REVIEW OF COST EFFECTIVENESS ANALYSIS OF IVABRADINE IN HEART FAILURE
    Dehghani, M.
    Varmaghani, M.
    Sharifi, F.
    VALUE IN HEALTH, 2016, 19 (07) : A645 - A645
  • [45] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF HEART FAILURE IN BRAZIL
    Lacey, M.
    Brouillette, M.
    Libanore, A.
    Lenhart, G.
    Tozato, C.
    Lopes, N.
    Russell, M.
    VALUE IN HEALTH, 2018, 21 : S63 - S63
  • [46] Cost-effectiveness of empagliflozin for the treatment of heart failure: a systematic review
    Liu, Jinyu
    Liu, Dong
    Gong, Xuepeng
    Wei, Anhua
    You, Ruxu
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [47] Cost-effectiveness of heart failure therapies
    Luis E. Rohde
    Eduardo G. Bertoldi
    Livia Goldraich
    Carísi A. Polanczyk
    Nature Reviews Cardiology, 2013, 10 : 338 - 354
  • [48] Cost-effectiveness of heart failure therapies
    Rohde, Luis E.
    Bertoldi, Eduardo G.
    Goldraich, Livia
    Polanczyk, Carisi A.
    NATURE REVIEWS CARDIOLOGY, 2013, 10 (06) : 338 - 354
  • [49] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF HEART FAILURE IN COLOMBIA
    Lacey, M.
    Brouillette, M.
    Karpf, E.
    Lenhart, G.
    Barbeau, M.
    Russell, M.
    VALUE IN HEALTH, 2017, 20 (09) : A613 - A613
  • [50] The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States
    Eckman, Mark H.
    Kaiser, Tiffany E.
    Sherman, Kenneth E.
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (11) : 1294 - 1306
12345